全文获取类型
收费全文 | 87335篇 |
免费 | 6870篇 |
国内免费 | 4066篇 |
专业分类
耳鼻咽喉 | 777篇 |
儿科学 | 1527篇 |
妇产科学 | 1381篇 |
基础医学 | 8364篇 |
口腔科学 | 1632篇 |
临床医学 | 11515篇 |
内科学 | 13108篇 |
皮肤病学 | 1355篇 |
神经病学 | 4294篇 |
特种医学 | 2671篇 |
外国民族医学 | 19篇 |
外科学 | 7299篇 |
综合类 | 14561篇 |
现状与发展 | 20篇 |
一般理论 | 12篇 |
预防医学 | 8347篇 |
眼科学 | 1612篇 |
药学 | 9052篇 |
85篇 | |
中国医学 | 4767篇 |
肿瘤学 | 5873篇 |
出版年
2024年 | 210篇 |
2023年 | 768篇 |
2022年 | 1979篇 |
2021年 | 2717篇 |
2020年 | 2138篇 |
2019年 | 2039篇 |
2018年 | 2189篇 |
2017年 | 2205篇 |
2016年 | 1969篇 |
2015年 | 3196篇 |
2014年 | 4213篇 |
2013年 | 4708篇 |
2012年 | 7334篇 |
2011年 | 7639篇 |
2010年 | 5766篇 |
2009年 | 5369篇 |
2008年 | 6217篇 |
2007年 | 6129篇 |
2006年 | 5825篇 |
2005年 | 5252篇 |
2004年 | 4072篇 |
2003年 | 3676篇 |
2002年 | 3095篇 |
2001年 | 1750篇 |
2000年 | 1411篇 |
1999年 | 1164篇 |
1998年 | 731篇 |
1997年 | 698篇 |
1996年 | 527篇 |
1995年 | 446篇 |
1994年 | 411篇 |
1993年 | 280篇 |
1992年 | 298篇 |
1991年 | 220篇 |
1990年 | 212篇 |
1989年 | 154篇 |
1988年 | 148篇 |
1987年 | 146篇 |
1986年 | 130篇 |
1985年 | 122篇 |
1984年 | 102篇 |
1983年 | 65篇 |
1982年 | 59篇 |
1981年 | 52篇 |
1980年 | 51篇 |
1979年 | 57篇 |
1978年 | 43篇 |
1977年 | 33篇 |
1975年 | 42篇 |
1974年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Acid-suppressive drugs, including histamine-2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), are common medications used for treating upper gastrointestinal tract disorders. However, acid-suppressive drugs have been reported to increase the risk of pneumonia in numerous disease populations. However, the relationship between acid-suppressive drugs and stroke-associated pneumonia (SAP) remains controversial.The purpose of this study was to investigate the association between acid-suppressive drug usage and pneumonia among patients with stroke by using a nationwide data set.A population-based cohort study was conducted using a data set from the Taiwanese National Health Insurance Research Database. Data on patients with new-onset stroke from 2010 to 2011 were collected. Patients with and without acid-suppressive drug usage were followed up to identify the occurrence of any type of pneumonia. We estimated the adjusted hazard ratios (HRs) by using the Cox proportional hazards model.The study cohort comprised 7965 patients with new-onset stroke. The incidence of pneumonia was 6.9% (552/7965) and more than 40% (225/552) of patients developed pneumonia within 3 months after an acute stroke. Acid-suppressive drug usage was an independent risk factor of pneumonia. The adjusted HR for the risk of pneumonia in patients with new-onset stroke using acid-suppressive drugs was 1.44 (95% confidence interval [CI] = 1.18–1.75, P < 0.01). Only PPI usage increased risk of chronic SAP (adjusted HR = 1.46, 95% CI = 1.04–2.05).Acid-suppressive drug usage was associated with a slightly increased risk of SAP. Physicians should exercise caution when prescribing acid-suppressive drugs to patients with stroke, particularly at the chronic stage. 相似文献
4.
5.
6.
7.
8.
9.
OBJECTIVES: To assess the effectiveness and safety of additional bedtime H2‐receptor antagonists (H2RAs) in suppressing nocturnal gastric acid breakthrough (NAB) via a systematic review. METHODS: Eligible trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 2, 2004), MEDLINE (January 1966–June 2004), EMBASE (January 1980–June 2004) and CINAHL (January 1982–June 2004). Additional hand‐searching was conducted on the proceedings of correlated conferences, eight important Chinese journals and references of all included trials. All randomized controlled trials evaluating H2RAs for the control of NAB were eligible for inclusion. The systematic review was conducted using methods recommended by The Cochrane Collaboration. RESULTS: Only two randomized crossover studies, comprising 32 participants, met the inclusion criteria. Because the design, dosage and duration of the treatments were different between the studies, it was not possible to conduct meta‐analysis. There were no consistent conclusions found between the two included studies in evaluating H2RAs for the control of NAB. CONCLUSIONS: No implications for practice at this stage can be concluded. Appropriately designed large‐scale randomized controlled trials with long‐term follow up are needed to determine the effects of additional bedtime H2RAs in suppressing NAB. 相似文献
10.
超顺磁性氧化铁标记大鼠骨髓基质细胞经门静脉移植MRI活体示踪的研究 总被引:9,自引:0,他引:9
目的观察1.5T场强MRI联合动物专用线圈是否可以活体示踪经门静脉移植的纳米级超顺磁性氧化铁颗粒标记的骨髓基质细胞(bone marrow stromal cells BMSCs),为介人性门静脉骨髓基质细胞移植治疗终末期肝脏疾病的研究提供进一步的依据。方法供体大鼠5只,梯度密度离心分离BMSCs,纳米级超顺磁性氧化铁颗粒和脂质体转染BMSCs,体外经普鲁士蓝染色和HE染色确定细胞标记率。受体大鼠15只,分为5组,分别为对照组和纳米级超顺磁性氧化铁颗粒标记的骨髓基质细胞经门静脉移植人正常大鼠肝脏后2h、3d、7d及2周组。1.5T场强MRI联合动物专用线圈行T1W、T2W和T2*序列扫描,观察肝脏信号改变情况,与对照组比较,并且与组织切片对照。结果纳米级超顺磁性氧化铁颗粒和脂质体转染BMSCs,细胞标记率〉95%。经门静脉移植人正常大鼠肝脏后,T2*序列扫描显示经标记的BMSCs在肝内显示弥漫性的结节性低信号影,移植后2h到2周均可见到细胞在受体肝脏内存在,组织学切片显示信号缺失部位与铁颗粒标记细胞相一致。结论纳米级超顺磁性铁氧体颗粒标记的大鼠BMSCs经门静脉移植后可以通过1、5T场强行MRI活体示踪,为临床干细胞移植的应用提供可行的示踪方法。 相似文献